Target Price | $9.50 |
Price | $1.24 |
Potential |
666.13%
register free of charge
|
Number of Estimates | 2 |
2 Analysts have issued a price target Enlivex Therapeutics Ltd 2025 .
The average Enlivex Therapeutics Ltd target price is $9.50.
This is
666.13%
register free of charge
$13.00
948.39%
register free of charge
$6.00
383.87%
register free of charge
|
|
A rating was issued by 2 analysts: 2 Analysts recommend Enlivex Therapeutics Ltd to buy, 0 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Enlivex Therapeutics Ltd stock has an average upside potential 2025 of
666.13%
register free of charge
|
Dec '23 |
2024 Estimates |
|
---|---|---|
Earnings Per Share $ | -1.56 | -0.65 |
7.69% | 58.33% | |
P/E | negative |
1 Analysts have issued a Enlivex Therapeutics Ltd forecast for earnings per share. The average Enlivex Therapeutics Ltd <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is
This results in the following potential growth metrics and future valuations:
Enlivex Therapeutics Ltd...
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.